Mectizan Donation Program | Local power. Global Change.
MERCK A program at The Task Force for Global Health
Switch to French site

MDP News & Resources

Looking for specific news & resource articles?
Enter a search phrase, select a category or topic, and click the green search button below.


Lymphatic Filariasis Eliminated in Malawi

28 October 2020

The World Health Organization (WHO) announced in this week’s WHO Weekly Epidemiological Record that Malawi has been validated to have eliminated lymphatic filariasis as a public health problem.

Resources and Tools

Managing Morbidity and Preventing Disability (MMDP) Toolkit

The World Health Organization (WHO) is developing a toolkit to help programs implement MMDP services. The toolkit incorporates relevant resources developed by WHO and partner institutions, and its objectives are as follows:

provide tools and templates for implementation of key activities to strengthen delivery by the health system of the recommended minimum package of care for LF patients make information and tools accessible to national LF programs and health professionals around the world identify and resolve gaps in resources

Components focus on the following areas:

Planning, including patient estimation Capacity Building to Deliver MMDP Services Documentation of MMDP services


Report from the 7th Meeting of the GAELF

This report summarizes the 7th meeting of the Global Alliance to Eliminate Lymphatic Filariasis (GAELF), Washington DC, November 18-19, 2012. The theme, “A Future Free of Lymphatic Filariasis: Reaching the Vision by Scaling Up, Scaling Down and Reaching Out”, emphasized new strategies and partnerships necessary to reach the 2020 goal of elimination of lymphatic filariasis (LF) as a public-health problem.

GAELFreport (1.32 MB)

WHO Guide

Lymphatic Filariasis: Managing Morbidity and Preventing Disability

Guide on planning, implementing and monitoring activities at national level. This guide provides the best available information on managing morbidity and preventing disability after acute dermatolymphangioadenitis (ADLA; acute attacks), lymphoedema or elephantiasis, and hydrocoele.

Scientific Publication

The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000–2007)

Abstract on the first 8 years of The Global Programme to Eliminate Lymphatic Filariasis. Hooper et al, Annals of Tropical Medicine & Parasitology, Volume 103, 2009 – Issue sup1.

Scientific Publication

The development of albendazole for lymphatic filariasis

This review examines the thinking and the processes behind the development of albendazole, from the first ideas in the mid 1980s to the establishment of the Global Programme to Eliminate Lymphatic Filariasis.

Scientific Publication

Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis

Abstract on progress made in preventing the disability of lymphatic filariasis, the monitoring and evaluation of such disability and its control, and the integration of disability prevention with mass drug administrations and efforts to control other disabling diseases.

Scientific Publication

Lymphatic filariasis: patients and the global elimination programme

Abstract addressing the central role that filariasis patients have played in the Tanzania Lymphatic Filariasis Elimination Programme to date, and covering some of the clinical successes achieved between 1999 and 2009.

Scientific Publication

GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis

Abstract on the unique private-sector collaboration of the pharmaceutical companies GlaxoSmithKline (GSK) and Merck & Co., Inc., Kenilworth, N.J., U.S.A.,* to support the global efforts to eliminate lymphatic filariasis, through donations of drugs to prevent the disease.

Scientific Publication

Challenges for the integration of mass drug administrations against multiple ‘neglected tropical diseases’

Abstract on the integration of mass drug administrations against multiple NTDs. Hopkins, Annals of Tropical Medicine & Parasitology, Volume 103, 2009 – Issue sup1.

Scientific Publication

A decade of ivermectin–albendazole donation for lymphatic filariasis

Article on a symposium held to commemorate the 10th anniversary of the donation of Mectizan® and albendazole for the elimination of lymphatic filariasis.

Scientific Publication

The Mectizan Donation Program (MDP)

Abstract on the Mectizan® Donation Program (MDP), which was launched in 1987 by Merck & Co., Inc., Kenilworth, N.J., U.S.A.* Thylefors, Annals of Tropical Medicine and Parasitology, 2008 Sep; 102 Suppl 1:39-44.